Affluent Medical SA ( (FR:AFME) ) just unveiled an announcement.
Affluent Medical has released its half-year liquidity contract report, detailing transactions and resources under the contract with Rothschild Martin Maurel. As of December 31, 2024, the liquidity account held 141,912 shares and €22,909 in cash. The report highlights the volume and value of buy and sell transactions conducted within the contract period, indicating active trading activity. This update reflects the company’s ongoing efforts to manage market liquidity and ensure stable trading conditions for its shares.
More about Affluent Medical SA
Affluent Medical SA operates in the healthcare industry, focusing on the development of innovative medical devices to treat cardiovascular diseases, urology, and interventional radiology. The company is listed on Euronext Paris and is headquartered in Aix-en-Provence, France.
YTD Price Performance: 1.98%
Average Trading Volume: 2,500
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €53.09M
For a thorough assessment of AFME stock, go to TipRanks’ Stock Analysis page.